Reduces macrophage and its TLR4 signaling in liver. Ameliorates inflammation by hindering Nod-Like Receptor Protein 3 Inflammasome as well as NF-κB signaling in NAFLD. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.